Mark E. Ketner

Senior Engineer and Principal Investigator

Mark holds a Ph.D. in Biomedical Engineering from the University of North Carolina at Chapel Hill and a Bachelor of Science in Chemical Engineering from North Carolina State University. With 15 years of experience in the processing of pharmaceuticals, Mark has extensive knowledge and experience with the production of pharmaceutical powders using spray drying and lyophilization techniques as well as knowledge in analytic and physical testing of pharmaceutical powders. Mark most recently worked with Becton Dickenson (BD) developing the atmospheric spray-freeze-drying (ASFD) process. His work at BD, funded by the United States Army Medical Research Institute for Infectious Disease, resulted in stable, aerodynamically light dry powders suitable for bio-defense vaccines for counterterrorism measures. Before working with BD, Mark worked for Oriel Therapeutics, Inc. as a Design Engineer. At Oriel Therapeutics, Inc., he contributed to the development of multi-dose dry powder inhalers and was a contributor on several patents. Before working at BD, Mark worked as an Engineer for Experimental Cardiology Group where he was responsible for the acquisition, monitoring and feedback control of cardiac electrolytes. At Engineered BioPharmaceuticals, Mark hopes to advance the state of the art technology in the production and distribution of dry powder pharmaceuticals.